1. Trang chủ
  2. » Y Tế - Sức Khỏe

Refractive Lens Surgery - part 4 doc

25 269 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 25
Dung lượng 491,35 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

That same year, Ruhswurm used only the +2.0-D toric power STIOL in 37 eyes with a mean preoperative refractive cylinder of 2.7 D and found 48% to achieve UCVA of 20/40 or better, with a

Trang 1

length), underwent full FDA clinical trial,

lead-ing to its approval in 1998 Data from the

over-all FDA study showed 76% of cases within 10

degrees, 88% within 20 degrees, and 95%

within 30 degrees of the intended cylindrical

axis The uncorrected visual acuity (UCVA) of

eyes with the STIOL was significantly

im-proved compared to those that received the

spherical IOL of similar design Two years

lat-er, the FDA went on to designate the STIOL as

a “new-technology” IOL due to its

demon-strated improvement of UCVA in astigmatic

patients when compared to a spherical IOL

Thereafter, the longer TL model was

intro-duced in the lower diopter powers (£24 D) as

a prophylactic against off-axis rotations in

these larger myopic eyes To date, both STIOL

models have been widely evaluated [34–41]

These reports are quite consistent in

demon-strating a predictable improvement in UCVA

with the STIOL, yet they do differ widely in the

occurrence of early off-axis rotation

In 2000, Sun and colleagues [35, 36]

retro-spectively compared 130 eyes that received

the Staar AA-4203-TF to 51 eyes that received

a spherical IOL with LRI The STIOL was

found to be superior to LRIs in producing

UCVA of≥20/40 (84% vs 76%) as well as in

reducing refractive cylinder to £0.75 D (55%

vs 22%) and to £1.25 D (85% vs 49%).

Twelve eyes (9%) underwent STIOL

reposi-tioning for off-axis rotation That same year,

Ruhswurm used only the +2.0-D toric power

STIOL in 37 eyes with a mean preoperative

refractive cylinder of 2.7 D and found 48% to

achieve UCVA of 20/40 or better, with a

re-duction of refractive cylinder to 0.84 D

post-operatively [37] No cases of STIOL rotation

greater than 30 degrees were observed,

al-though 19% rotated up to 25 degrees

One year later, Leyland’s group used vector

analysis software to calculate the magnitude

of expected correction produced by the

STI-OL in 22 eyes [38] The group achieved 73%

of the planned reduction of astigmatism,

in-cluding the 18% of cases that experienced

off-axis rotation by more than 30 degrees In

a smaller study of four eyes, a digital overlaytechnique was used to measure precisely theSTIOL axis postoperatively; 75% of eyes weredetermined to be within 5 degrees and clini-cal slit-lamp estimates of axis were found to

be quite precise in all cases [39] All these ports exclusively studied the shorter TF mod-

re-el, as it was the only design available to theinvestigators at the time of their studies.More recent studies include data on thelonger TL model Till reported on 100 eyes andfound a magnitude of reduction of 1.62 D forthe +2.0-D toric power and 2.86 D for the +3.5-

D power in the 89% of eyes that were observed

to be within 15 degrees of the intended axis[40] No difference in rotation rate betweenSTIOL models was observed In contrast,Chang compared the 50 cases receiving thelonger TL model against the 11 receiving theshorter TF model and found a significant dif-ference in rotation rates specifically for the TFgroup in the lower diopter range [41] No case

of rotation of more than 10 degrees was served in any of the 50 eyes with the TL or inthe five eyes with the higher-power TF Howev-

ob-er, three of six eyes with the lower-power TFmodel required repositioning This stronglysuggests that lengthening the original (short)

TF model in the lower power range (£24 D)

may prove to be very beneficial in ing early off-axis rotations of the STIOL

discourag-In summary, the STIOL has been widelystudied, with the reports showing a consis-tent, predictable effect of reduction of preop-erative refractive cylinder for the group ofeyes studied The variability in the magnitude

of correction of the STIOL in these numerousstudies is not surprising, as the amount ofrefractive (spectacle) astigmatism correction

of a given IOL varies with the overall tive error of each patient [42]; myopes willachieve greater spectacle correction of astig-matism than hyperopes due to vertex-dis-tance issues Regardless, the STIOL has beenclearly shown to be highly predictable in thecorrection of astigmatism at the time of re-fractive lens surgery

Trang 2

Another consistent finding of these

clini-cal studies is that, although each group of

eyes studied shows good efficacy of mean

cylinder reduction by the STIOL, a small

per-centage of individuals were found to

experi-ence an early significant off-axis rotation The

variability in these findings is likely

multifac-torial First, earlier studies used the shorter

STIOL exclusively (TF model), which is now

thought to be of inadequate length for larger

eyes [34–39] Some later reports that included

the TL model did not provide

diopter-specif-ic data on whdiopter-specif-ich TF cases underwent rotation

[40] Change provided the one study that

detailed the diopter-specific results of each

STIOL model, and the longer TL model in the

lower diopter range showed no rotations [41],

suggesting that recent design modifications

of the STIOL may indeed improve future

outcomes Second, surgical technique varies

among surgeons, including the completeness

of viscoelastic removal between the STIOL

and the posterior capsule Third, the axis of

implantation was marked on the eye

preoper-atively in the upright position by some

inves-tigators, while others used a Mendez gauge at

the time of implantation; torsional rotation of

the eye that occurs in the recumbent position

may have produced mild misalignments in

some cases Next, a few cases of implantation

on the improper axis were suspected in some

reports, yet these eyes were included in the

calculation of overall rate of STIOL

malposi-tion Finally, and most obviously, there is

clearly a tendency for the STIOL to rotate

spontaneously within the capsule between

the time of implantation and the first

post-operative day examination

Regardless of the reasons for variability

among rates of off-axis rotation, it is clear

that occasional cases of off-axis alignments

will be encountered It is not known why

some individuals experience spontaneous

ro-tational malposition of the STIOL in the

ear-ly postoperative period Presumabear-ly there is a

disparity in size between the capsule and the

STIOL in some eyes Larger capsules may be

found in myopic eyes as well as in cases ofenlarged, hard, and more advanced 4+ nuclei[43, 44] Other factors, including eye rubbing

or digital compression, may play a role insome cases Fortunately, these same clinicalstudies that document early malpositionsalso clearly demonstrate that repositioning ofthe off-axis STIOL after 1 or 2 weeks uniform-

ly restores the desired effect, and late tions are very rare

rota-Other clinical studies have used the STIOL

to correct excessive astigmatism with novelprocedures To correct excessive amounts ofastigmatism, Gills combined LRIs with theSTIOL or used multiple STIOLs in “piggy-back” fashion [45–47] Other suggestions thathave not been well studied include placing amultifocal IOL in the sulcus as a piggybackover a bag-fixated toric IOL, or using toricIOLs to create pseudo-accommodation byleaving a residual refractive cylinder to aid inreading

In summary, these numerous clinical ies have clearly demonstrated the clinical re-sults that can be expected when using theSTIOL to produce improved UCVA in astig-matic eyes undergoing lens refractive sur-gery We now turn our attention to the specif-

stud-ic recommendations with whstud-ich refractivelens surgeons must be familiar to achieve thebest clinical outcomes for their patients

7.4 Using the STIOL 7.4.1 Preoperative Issues

One of the advantages of using the STIOL forthe correction of astigmatism is that refrac-tive lens surgeons must learn few new tech-niques or procedures No significant changes

to spherical IOL calculations are required, but

a few specific steps must be taken to insure asuccessful outcome when using the STIOL

The first step is for surgeons to review cent cases and determine the keratometricchanges that occur postoperatively in their

re-Chapter 7 Correction of Keratometric Astigmatism 63

Trang 3

hands While most refractive lens surgeons

today use clear cornea incisions of 3.0 mm or

less and do not induce significant astigmatism,few,

if any,create truly “astigmatically neutral”incisions

Thus,it is important to review the way in which the

cornea changes,as it is the goal of STIOL

implanta-tion to treat the postoperative,not preoperative

ker-atometry

The next step is to calculate the STIOL

power The STIOL is available in SE powers

from 9.5 to 28.5 D, and each SE power is

avail-able in two distinct toric powers (+2.0 and

+3.5 D) The surgeon’s preferred IOL

calcula-tion formula is used in an identical fashion as

with spherical IOLs to determine the STIOL

SE power If the SE power is between 21.5 and

23.5 D, a choice of IOL models must be made

Due to the increased rotational stability

demonstrated by Chang [41], the longer TL

model should be chosen The unique step

re-quired when using the STIOL is to choose

either the +2.0-D toric power or the +3.5-D

toric power as determined by keratometry

Due to vertex distance issues, a perfectly

aligned +2.0-D STIOL is expected to correct

1.4 D of keratometric cylinder, and the

+3.5-D STIOL corrects 2.3 D of regular

corneal astigmatism Thus, the manufacturer

recommends that the +2.0-D toric power

STIOL be used for preoperative keratometric

astigmatism between 1.4 and 2.2 D; the

+3.5-D toric power is used when the

ker-atometry shows greater than 2.2 D of

astig-matism (Fig 7.2) Therefore, the only

differ-ence in choosing the power of the STIOL

compared to a spherical IOL is that the toric

power must be specified Adjustments to the

calculations are not needed otherwise

Once the specific STIOL is selected, the tended axis of implantation is then deter-mined and recorded The STIOL is a plus-cylinder lens, and should be aligned as wouldany plus-cylinder lens to neutralize the ker-atometric astigmatism

in-Topography is strongly encouraged to ify that the astigmatism is regular and to as-sist with determination of the steep cornealaxis Irregular corneal astigmatism will not

ver-be appropriately corrected by the STIOL Thechosen axis for STIOL alignment must bedocumented for later use in the operatingroom unless qualitative keratometry is to beused intraoperatively to align the STIOL.Finally, on the day of surgery, the eyeshould be marked with the patient in the up-right position to avoid misalignments due totorsional changes that may occur in the re-cumbent position Some surgeons allow thepreoperative team to do this, while others willnot delegate this duty A marking pen may beused at either the vertical or horizontalmeridian for later orientation with a Mendezgauge to insure proper alignment of the STI-

OL at the time of implantation Alternatively,qualitative keratometry may be used intraop-eratively, in which case this step may be omit-ted

7.4.2 Implanting the STIOL

Implanting the STIOL is similar to

implanti-ng other plate-haptic IOLs from the samemanufacturer As with all plate-haptic IOLs,the STIOL should not be implanted without

an intact capsule and complete continuouscurvilinear capsulorrhexis Current cartridgedesign allows delivery through a 3.0-mmclear cornea incision The cartridge tip doesnot need to enter entirely into the anteriorchamber, but does need to enter fully thecorneal incision Retracting the plunger sev-eral times as the STIOL is pushed down thecartridge is required to insure no overriding

of plunger that could tear the trailing haptic

Fig 7.2. Standard nomogram for choosing STIOL

toric power based on the amount of preoperative

keratometric astigmatism

K-Astigmatism

<1.4 1.4 –2.3

≥2.4

Toric Power 0 +2.0 +3.5

Trang 4

The leading haptic is placed into the capsule

filled with viscoelastic, and the trailing haptic

is placed with a second instrument as with

other plate-haptic IOLs

Once the STIOL is placed fully within the

capsule, the STIOL is oriented into the

de-sired axis Careful removal of viscoelastic

from between the posterior capsule and the

STIOL is important to help stabilize the

im-plant from early rotation, and this is done

pri-or to final pri-orientation along the desired axis

The axis is determined using the previously

placed limbal orientation marks or using

qualitative keratometry with projected light

After final irrigation/aspiration of

viscoelas-tic and verification of a water-tight incision,

the STIOL orientation is again checked Some

surgeons prefer to leave the eye slightly soft to

encourage early contact between the capsule

and the STIOL

7.4.3 Postoperative Management

Management of eyes with the STIOL

implant-ed is similar to spherical IOL cases If an

off-axis rotation of the STIOL is encountered, it is

best managed on an individual basis As

clin-ical studies have shown, off-axis rotations of

the STIOL may occur in the very early

post-operative period, with later rotations rarely

observed In most cases of mild rotation, the

UCVA remains excellent and no intervention

is needed For larger rotations, the patient’s

tolerance of the malposition should be

con-sidered In refractive lens surgery, where

pa-tients have an intense desire for excellent

UCVA, even moderate rotations may require

repositioning to the desired axis The best

time for repositioning is 2–3 weeks after

im-plantation If repositioned earlier, capsule

fi-brosis may not be sufficient to prevent the

lens from returning to its original

malposi-tion After 3 weeks, the fibrosis of the capsule

intensifies, making repositioning more

diffi-cult After 2–3 months, the capsule assumes

the orientation of the long axis of the

plate-haptic with significant fibrosis, and tioning to a new axis is difficult if not im-possible Although some eyes may requireNd:YAG capsulotomy for posterior capsuleopacification, there have been no reports ofSTIOL malposition occurring after lasertreatment

reposi-7.5 Improving Outcomes

with the STIOL:

Author’s Observations and Recommendations

Experience with the STIOL over the past

6 years has provided several important sights that have improved the author’s clinicaloutcomes when using the STIOL for refrac-tive lens surgery Discouraged by the occa-sional off-axis rotations in the first year afterFDA approval, the author considered discon-tinuing use of the STIOL at the same time thatdata were becoming available that suggested

in-a novel method to promote stin-abilizin-ation ofthe STIOL against rotation As reported pre-viously [48], implanting the STIOL in a “re-versed” position, with the toric surface facingthe posterior capsule rather than the anteriorcapsule, appeared to improve but not cure thefrequency of off-axis rotations The rationalefor initially implanting the STIOL in thismanner, and the findings that resulted, will bebriefly reviewed here, with additional in-sights to follow

Why was the STIOL ever intentionally planted in the reversed position? After FDAapproval and initial enthusiasm for resultsobtained with the STIOL, occasional patientswere encountered with “borderline” astigma-tism For example, a patient may present with1.2 D of corneal astigmatism, which is belowthe manufactured suggested limit of 1.4 D.The STIOL could “flip” the astigmatic axis insuch a patient However, theoretical opticscalculate that the toric power of the STIOLwould be decreased by 8% if the optic wasreversed, as the toric (anterior) surface of the

im-Chapter 7 Correction of Keratometric Astigmatism 65

Trang 5

STIOL in the reversed position would then be

closer to the nodal point of the eye and less

effective toric power would result without

changing the SE For these borderline

pa-tients, the STIOL was intentionally reversed,

and the results were startling

The first observation occurred when the

implant was placed into the capsule in the

re-versed position Compared with the normal

position, the reversed position seemed to

re-sist manipulation when rotating the STIOL

into the desired axis Although this

observa-tion was interesting, the significance of it was

not immediately realized, and implanting the

STIOL in the reversed position was reserved

for only those occasional eyes with

border-line astigmatism Later, the first years’ data

were analyzed and suggested that eyes with

the optic reversed showed outstanding

out-comes While the reason for these results may

have been multifactorial, the decision was

made to implant all STIOLs in the reversed

position, and the resulting data further

sug-gested that this technique was useful in

re-ducing the rate of malpositions

A retrospective analysis was performed on

171 eyes Postoperative UCVA and residual

refractive cylinder were compared between

eyes implanted with the STIOL in the

stan-dard vs reversed position Surprisingly, a

sta-tistically significant increase in the

percent-age of eyes achieving 20/40 or better UCVA

was found for the STIOL in the reversed vs

standard position (83% vs 58%

respective-ly) Also, there was a significantly improved

UCVA for the STIOL in the reversed vs

stan-dard position (0.60 ± 0.18 vs 0.49 ± 0.21).

Finally, the reverse-STIOL position group

showed a significant increase in the

percent-age of eyes achieving a residual refractive

cylinder £0.5 D (56% vs 34%).

Thus, the STIOL in the reversed position

was observed to promote improved UCVA

and reduction of refractive cylinder despite

an expected 8% reduction of toric power in

this position It is proposed that the STIOL

was more stable in this reversed position, and

fewer off-axis rotations occurred The moreprecise rotational alignment was more im-portant than the very mild reduction of toricpower

These data are not to be interpreted thatthe “reversed” STIOL provides more toricpower On the contrary, a perfectly alignedSTIOL with the toric surface facing the ante-rior capsule will correct more corneal astig-matism than the same lens in the reversedposition The importance of the reversed po-sition is that it stabilizes the STIOL againstrotation Therefore, for a large group of eyes,more reversed STIOLs will be on-axis, andthe mean UCVA will be improved

Therefore, based on these findings, it isrecommended that all eyes be implanted withthe optic of the STIOL intentionally reversed,and the toric power is chosen based on themodified “reversed” nomogram (Fig 7.3) Forkeratometric asymmetry of 1.2–2.1 D, use the+2.0-D toric power in the reversed position,and for corneal astigmatism above 2.2 D, usethe +3.5-D STIOL in the reversed position.Using this nomogram will insure the axis isnot overcorrected and, together with otherrecommendations here, will help to minimizethe frequency of off-axis rotations

In addition to using the reversed gram and implanting the STIOL in thereversed position to discourage early malpo-sitions, other observations and recommen-dations are shared here as the chapter closes.With regards to preoperative recommen-dations, aside from using the “reversed”nomogram to choose the toric power of theSTIOL, the main problem to avoid is eyes withirregular astigmatism Obviously, topograph-ical data are required to detect such cases Aprudent protocol is to have all patients withmore than 1.25 D of keratometric asymmetrywho are scheduling for surgery to undergotopography Another suggestion specificallyfor clear lens extraction patients who are ex-pecting excellent UCVA is to inform the pa-tient about the potential need for reposition-ing While most patients do not need such

Trang 6

intervention, those that do are very accepting

of such intervention when they are prepared

in advance If repositioning is performed in

the operating room, which is suggested,

fi-nancial arrangements for such a procedure

should likewise be understood in advance A

reasonable approach is to estimate the

fre-quency of returning to the operating room

for 100 patients, then calculate the costs for

those visits, and incorporate that cost into the

overall charge to all patients If cash-pay

pa-tients who require repositioning are charged

for the procedure, they feel a

“double-wham-my” of requiring a second surgery and having

to pay for it

Intraoperative suggestions start with the

recommendation of implanting all STIOLs in

the reversed position to promote rotational

stability Simply open the package, grasp the

STIOL, turn the upward (anterior) surface

to-ward the floor, and load it into the cartridge,

thus reversing the optic The second

sugges-tion is to use endocapsular

phacoemulsifica-tion techniques rather than flipping

tech-niques The frequency of STIOL off-axis

rotations was found to increase dramatically

for cases in which the nucleus was

“tire-ironed” into a vertical position and

under-went phaco-flip (data not shown) While the

reasons for this observation are unknown, it is

suspected that increased manipulation of the

capsule while prolapsing and emulsifying the

nucleus with the flip technique caused some

stretching or enlargement of the capsule

At the time of implantation, it is

recom-mended to avoid a rapid expulsion of the

lens; if it “shoots” into the capsular bag, there

is a tendency for the STIOL to rotate towardsthe axis that it was forced into the bag A gen-tle “push-pull” retraction of the plunger isuseful in delivering the leading haptic slowlyinto the capsule Next, the choice of viscoelas-tics may be important, as pointed out byChang [41], who recommends avoiding dis-persive viscoelastics that coat the IOL such asViscoat He achieved good results with sodi-

um hyaluronate 1.0%, while the author erally uses methylcellulose 1% (Occucoat)with good results As mentioned previously, it

gen-is critical to remove the vgen-iscoelastic from hind the IOL to prevent early rotations Next,when moving the STIOL into its final posi-tion, it is recommended to rotate both sides ofthe optic to promote equal forces on all sides

be-of the implant Finally, it is critical to recheckthe STIOL axis at conclusion of the surgery,including after speculum and drape removal.Postoperative management recommenda-tion includes the use of a shield at bedtimeover the operative eye Patients may place thisthemselves There is a suspicion that someoff-axis rotations may occur overnight due toexternal pressure in those eyes without ashield If repositioning is needed, a sterilefield in the operating room is strongly recom-mended for safety, but some surgeons may in-tervene at the slit-lamp Repositioning in theoperating room may be performed through aparacentesis with a cystatome on a BSS free-flow line Gentle rocking on both sides of theoptic will free early capsule adhesions, andthe STIOL is rotated to the desired axis with-out the need of a keratome incision or vis-coelastic

In conclusion, this chapter has reviewedthe clinical aspects important to understand-ing the development and use of the STIOL.This lens is quite effective in treating cornealastigmatism at the time of lens refractive sur-gery, yet occasional patients may requirerepositioning of the STIOL in the early post-operative period, with resulting excellentUCVA As improvements in STIOL designcontinue and as our understanding increases

Chapter 7 Correction of Keratometric Astigmatism 67

Fig 7.3. “Reversed” nomogram for choosing

STIOL toric power based on planned reversal of

STIOL optic to aid in stabilization against off-axis

Trang 7

about the dynamics at work in the eye during

the perioperative period, there are high

ex-pectations that our refractive lens patients

with significant astigmatism will consistently

reach emmetropia

References

1 Fine IH, Hoffman RS (1996) Refractive aspects

of cataract surgery Curr Opin Ophthalmol 7:

21–25

2 Hoffer KJ (1980) Biometry of 7,500 cataractous

eyes Am J Ophthalmol 90:360–368; correction

890

3 Grabow HB (1994) Intraocular correction of

refractive errors In: Kershner RM (ed)

Refrac-tive keratotomy for cataract surgery and the

correction of astigmatism Slack, Thorofare,

NJ, pp 79–115

4 Bear JC, Richler A (1983) Cylindrical refractive

error: a population study in western

New-foundland Am J Optom Physiol Opt 60:39–45

5 Attebo K, Ivers RQ, Mitchell P (1999)

Refrac-tive errors in an older population: the Blue

Mountain Eye study Ophthalmol 106:1066–

1072

6 Wang Q, Klein R, Moss SE (1994) Refractive

status in the Beaver Dam Eye Study Invest

Ophthalmol Vis Sci 35:4344–4347

7 Maloney WF, Sanders DR, Pearcy DE (1990)

Astigmatic keratotomy to correct preexisting

astigmatism in cataract patients J Cataract

Re-fract Surg 16:297–304

8 Osher RH (1992) Transverse astigmatic

kera-totomy combined with cataract surgery In:

Thompson K, Waring G (eds) Contemporary

refractive surgery Ophthalmology Clinics of

North America Saunders, Philadelphia, pp

717–725

9 Price FW, Grene RB, Marks RG et al (1995)

Astigmatism reduction clinical trial: a

multi-center prospective evaluation of the

pre-dictability of arcuate keratotomy Arch

Oph-thalmol 113:277–282

10 Kershner RM (1995) Keratolenticuloplasty:

arcuate keratotomy for cataract surgery and

astigmatism J Cataract Refract Surg 21:274–277

11 Buzard KA, Laranjeira E, Fundingsland BR

(1996) Clinical results of arcuate incisions to

correct astigmatism J Cataract Refract Surg

22:436–440

12 Troutman RC, Swinger C (1980) Relaxing sion for control of postoperative astigmatism following keratoplasty Ophthalmology 11: 117–120

inci-13 Gills JP (1997) Optimizing vision with limbal relaxing incisions Ophthalmol Management 1:2

14 Budak K, Friedman NJ, Kock DD (1998) bal relaxing incisions with cataract surgery.

Lim-J Cataract Refract Surg 24:503–508

15 Muller-Jensen K, Fischer P, Siepe U (1999) bal relaxing incisions to correct astigmatism

Lim-in clear corneal cataract surgery J Refract Surg 15:586–589

16 Nichamin LD, Wallace RB (2001) Reducing astigmatism In: Wallace R (ed) Refractive cataract surgery and multifocal IOLs Slack, Thorofare, pp 167–172

17 Ayala M, Perez-Santonja JJ, Artola A et al (2001) Laser in situ keratomileusis to correct residual myopia after cataract surgery J Re- fract Surg 17:12–16

18 Nichamin LD (2003) Bioptics for the phakic patient In: Gills JP (ed) A complete guide to astigmatism management Slack, Thorofare

pseudo-19 McDonnell PJ, Moreira H, Garbus J et al (1991) Photorefractive keratectomy to create toric ablations for correction of astigmatism Arch Ophthalmol 109:710–713

20 Artola A, Ayala M, Claramonte P et al (1999) Photorefractive keratectomy for residual myo- pia after cataract surgery J Cataract Refract Surg 25:1456–1460

21 Shepherd JR (1989) Correction of preexisting astigmatism at the time of small incision cataract surgery J Cataract Refract Surg 15:55–57

22 Lever J, Dahan E (2000) Opposite clear corneal incisions to correct preexisting astigmatism

in cataract surgery J Cataract Refract Surg 26:803–805

23 Kohnen T, Koch DD (1996) Methods to control astigmatism in cataract surgery Curr Opin Ophthalmol 7:75–80

24 Budak K, Yilmaz G, Aslan BS, Duman S (2001) Limbal relaxing incisions in congenital astig- matism: 6 month follow-up J Cataract Refract Surg 27:715–719

25 Frohn A, Dick HB, Thiel HJ (1999) tion of a toric poly(methyl methacrylate) in- traocular lens to correct high astigmatism.

Implanta-J Cataract Refract Surg 25:1675–1678

Trang 8

26 Shimizu K, Misawa A, Suzuki Y (1994) Toric

in-traocular lenses: correcting astigmatism while

controlling axis shift J Cataract Refract Surg

20:523–526

27 Schwartz DM, Jethmalani JM, Sandstedt CA,

Kornfield JA, Grubbs RH (2001) Post

implanta-tion adjustable intraocular lenses Ophthalmol

Clin North Am 14:339–345

28 Tehrani M, Stoffelns B, Dick B (2003)

Implanta-tion of a custom intraocular lens with a

30-diopter torus for the correction of high

astigmatism after penetrating keratoplasty.

J Cataract Refract Surg 29:2444–2447

29 Sanders DR, Grabow HB, Shepherd J (1992)

The toric IOL In: Grills JP, Martin RG, Sanders

DR (eds) Sutureless cataract surgery Slack,

Thorofare, NJ, pp 183–197

30 Gills JP, Martin RG, Thornton SP, Sanders DR

(eds) (1994) Surgical treatment of

astigma-tism Slack, Thorofare, NJ, pp 159–164 Martin

RG, Gills JP, Sanders DR (eds) (1993) Foldable

intraocular lenses Slack, Thorofare, NJ, pp

237–250

31 Patel CK, Ormonde S, Rosen PH, Bron AJ

(1999) Postoperative intraocular lens rotation:

a randomized comparison of plate and loop

haptic implants Ophthalmology 106:2190–

2195; discussion 2196

32 Hwang IP, Clinch TE, Moshifar M et al (1998)

Decentration of 3 piece versus plate-haptic

silicone intraocular lenses J Cataract Refract

Surg 24:1505–1508

33 Grabow HB (1994) Early results with foldable

toric IOL implantation Eur J Implant Refract

Surg 6:177–178

34 Grabow HB (1997) Toric intraocular lens

report Ann Ophthalmol 29:161–163

35 Sun XY, Vicary D, Montgomery P, Griffiths M

(2000) Toric intraocular lenses for correcting

astigmatism in 130 eyes Ophthalmology 107:

1776–1781

36 Kershner RM (2000) Toric intraocular lenses

for correcting astigmatism in 130 eyes

(discus-sion) Ophthalmology 107:1781–1782

37 Rushwurm I, Scholz U, Zehetmayer M, meyer G,Vass C, Skorpik C (2000) Astigmatism correction with a foldable toric intraocular lens in cataract patients J Cataract Refract Surg 26:1022–1027

Hansel-38 Leyland M, Zinicola E, Bloom P, Lee N (2001) Prospective evaluation of a plate haptic toric intraocular lens Eye 15:202–205

39 Nguyen TM, Miller KM (2000) Digital overlay technique for documenting toric intraocular lens axis orientation J Cataract Refract Surg 26:1496–1504

40 Till JS, Yoder PR, Wilcox TK et al (2002) Toric intraocular lens implantation: 100 consecutive cases J Cataract Refract Surg 28:295–301

41 Chang DF (2003) Early rotational stability of the longer Staar toric intraocular lens: fifty consecutive cases J Cataract Refract Surg 29: 935–940

42 Novis C (2000) Astigmatism and toric ular lenses (review) Curr Opin Ophthalmol 11:47–50

intraoc-43 Vasavada A, Singh R (1998) Relationship tween lens and capsular bag size J Cataract Re- fract Surg 24:547–551

be-44 Vass C, Menapace R, Schmetterer K et al (1999) Prediction of pseudophakic capsular bag diameter based on biometric variables.

J Cataract Refract Surg 25:1376–1381

45 Gills J, van der Karr M, Cherchio M (2002) Combined toric intraocular lens implantation and relaxing incisions to reduce high preexist- ing astigmatism J Cataract Refract Surg 28: 1585–1588

46 Gills JP (2003) Sutured piggyback toric traocular lenses to correct high astigmatism.

in-J Cataract Refract Surg 29:402–404

47 Gills JP, van der Karr MA (2002) Correcting high astigmatism with piggy back toric in- traocular lens implantation J Cataract Refract Surg 28:547–549

48 Bylsma S (2004) Toric intraocular lenses.In: Roy

FH, Arzabe CW (eds) Master techniques in cataract and refractive surgery Slack, Thorofare

Chapter 7 Correction of Keratometric Astigmatism 69

Trang 9

Astigmatism is caused by refractive

aberra-tions in the cornea or lens that focus light

un-evenly onto the retina, consequently

distort-ing images In recent years there has been

increasing interest in correcting astigmatism

at the time of cataract surgery or clear lens

ex-change to achieve emmetropia Cataract

sur-geons and their patients today hope to achieve

20/20 or better visual acuity and not have to

rely on spectacles or contact lenses for the

cor-rection of distance vision Approximately

15–29% of cataract patients have astigmatism

measuring more than 1.50 D of corneal or

re-fractive astigmatism [1, 2] Pre-existing

astig-matism is due to lens or corneal aberrations,

while post-surgically-induced astigmatism

results from incision wounds made in the

course of surgery that affect the cornea

Historically, alternatives for the correction

of astigmatism subsequent to cataract

sur-gery included the utilization of: contact

lens-es, glasslens-es, or refractive surgery post-cataractsurgery This spectacle dependency followingcataract surgery continued until the toric in-traocular lens (IOL) was introduced in 1998[3] Prior to the development of the toric IOL,two surgical procedures were considered forcorrecting pre-existing astigmatism: astig-matic keratotomy (incisional limbal or cornealrelaxation) and varying the length and loca-tion of the cataract incision [4] More recent-

ly, the excimer laser has become anotheralternative to implantation of a toric IOL forthe correction of astigmatism

The results of astigmatic keratotomy havebeen relatively unpredictable and may induceundercorrection or overcorrection of astig-matism [5, 6] In addition, there is a limit tohow much cylinder can be corrected by usingcorneal incisions and/or varying the incisionsite A study performed by Gills et al deter-mined that patients with very high astigma-

Correction of Keratometric Astigmatism:

AcrySof Toric IOL

Stephen S Lane

CORE MESSAGES

2 AcrySof toric IOL clinical results demonstrated improved

uncorrect-ed visual acuity, best spectacle-correctuncorrect-ed visual acuity, and runcorrect-educuncorrect-edastigmatic refractive cylinder when compared to AcrySof IOL,monofocal lens

2 AcrySof toric IOL’s biomaterial and truncated edged optic designreduce posterior capsule opacification accumulation

2 Implantation utilizing a toric IOL offers greater predictability andreversibility than astigmatic keratotomy

8

Trang 10

tism (>5.00 D) may benefit from the

combi-nation of corneal or limbal incisions with

toric IOL implants when the amount of

cylin-der present exceeds the powers available with

a toric IOL alone [7] The high cost of excimer

laser correction makes this a less desirable

alternative for cylinder correction for many

people

An effective toric IOL must have the

capa-bility of improving visual acuity and

main-taining rotational stability so as not to

dimin-ish the effects of the correction provided by

the toric lens

8.1 AcrySof Toric IOL

Alcon Laboratories Inc has recently

devel-oped an exceptionally stable toric IOL to aid

in the correction of astigmatism (Fig 8.1)

The AcrySof toric IOL, model SA60TT, is

de-signed to focus the light, otherwise scattered

by corneal and/or lenticular astigmatism, in

order to limit image distortion The AcrySof

toric IOL corrects for aphakia as well as

pre-existing or post-surgically-induced corneal

astigmatism The structure of the AcrySof

toric IOL is based on the presently marketed

AcrySof single-piece IOL, SA60AT monofocal

lens The toric lens design is comprised of a

foldable, single-piece, acrylic polymer, with

UV absorber The AcrySof toric IOL is

intend-ed for long-term use and is implantintend-ed into the

capsular bag following phacoemulsification

Its overall length is 13.0 mm with a 6.0 mm

diameter asymmetrical biconvex optic This

IOL easily folds in half and may be inserted

through an incision measuring between

3.0 and 3.5 mm using the Monarch II

Injec-tor Larger incision lengths may result in

an increase in surgically induced corneal

astigmatism The AcrySof toric IOL

exam-ined in a clinical investigation was provided

in three cylinder powers at the IOL plane:

1.50 D, 2.25 D, and 3.00 D Additional power

options are intended to be available to the

market The SA60TT covers a spherical range

between 16.0 D and 25.0 D in 0.5-D ments

incre-The AcrySof toric IOL’s material and sign offer a number of advantages Posteriorcapsule opacification (PCO), also known as asecondary cataract that forms over the visualaxis, often impairs visual acuity This compli-cation was reported more frequently withearlier IOL designs Two major features of theAcrySof toric IOL limit PCO The first is theAcrySof biomaterial, which adheres to thecapsular bag via a single layer of lens epithe-lial cells The resulting lack of space throughwhich essential life-sustaining nutrients canpass to and from these cells ultimately leads

de-to their death and subsequently de-to the directadherence of the AcrySof material to the cap-sular bag via common extracellular proteinssuch as fibronectin and collagen IV Thisoverall process is sometimes referred to asthe “no space, no cells” concept, which creates

Fig 8.1. The AcrySof toric IOL: the lens is marked with three alignment dots on each side to delineate the axis of the cylinder to be aligned on the steep meridian (Courtesy of Alcon Laboratories Inc.)

Trang 11

an unfavorable environment for cell

prolifer-ation [8] In addition to this biomaterial

ad-hesive property being effective at aiding in

the reduction of PCO, it may also account for

the exceptional rotational stability necessary

for a successful toric IOL

The second feature of the AcrySof toric IOL

that increases its ability to maintain a clear

posterior capsule and ultimately reduces the

need for a Nd:YAG capsulotomy is the design

of the posterior optic edge [8, 9] Nishi et al

demonstrated in an animal study that the

sharp-edged optic design of the AcrySof IOL

incorporates a PCO-reducing effect [10]

Proven in a separate study, the AcrySof IOL’s

square truncated optic edge created a barrier

to migration of lens epithelial cells, leaving the

visual axis clear of PCO [8]

The stable-force haptics are another

bene-ficial design attribute of the AcrySof toric

IOL These haptics are designed for

maxi-mum conformance to the capsular bag,

offer-ing the greatest possible surface area for

ad-herence between the IOL and the capsular

tissue This in turn leads to greater stability of

the IOL, and to a pronounced “shrink-wrap”

effect (Fig 8.2), which takes place during the

early postoperative time course It is this

property that is likely responsible for ing” the lens in place

“lock-In essence, the AcrySof single-piece IOLplatform provides the ideal material and de-sign features for a toric IOL The soft acrylicmaterial allows for small-incision surgery, thenatural PCO reduction characteristics allowfor fewer postoperative complications, andthe adhesion and capsular bag conformanceproperties allow for highly stable and pre-dictable positioning of the IOL

sur-9 o’clock limbus while the patient is in an right position Once the patient is positionedfor surgery, a Dell astigmatism marker is used

up-to mark the axis of the steep corneal

meridi-an using the previously placed 3 meridi-and 9 o’clock

Chapter 8 Correction of Keratometric Astigmatism 73

Fig 8.2. AcrySof toric

IOL implanted into

the eye (Courtesy

of Stephen Lane, MD)

Trang 12

marks as reference points for the 180-degree

meridian Following phacoemulsification, the

IOL is inserted into the capsular bag utilizing

a Monarch II injector Following insertion,

the lens begins to unfold naturally within the

capsule The surgeon then carefully aligns

axis indication marks on the IOL with the

steep meridian of the cornea Care must be

taken to remove the ophthalmic viscosurgical

device (OVD) from behind the IOL without

disrupting the IOL position A final

position-ing step followposition-ing OVD removal may be

nec-essary to reposition the lens on axis

One key for a successful surgical outcome

is choice of astigmatic power of the IOL and

the proper identification of the axis of the

steep meridian of the cornea Both are

calcu-lated using software provided by Alcon

Labo-ratories Inc., called the toric IOL calculator

The A-constant and keratometric analysis are

entered into the software, and the toric IOL

calculator uses this information, along with

an assumption of the astigmatic effects of the

cataract incision, in order to calculate the

appropriate astigmatic power correction and

position of the steep axis

8.3 US Clinical Trial Results

Best spectacle-corrected visual acuity

(BSCVA), uncorrected visual acuity (UCVA),

residual astigmatism, and lens rotation were

assessed during a comparative, multi-center,

prospective, clinical trial between the AcrySof

toric IOL, model SA60TT (SA60T3, SA60T4,

SA60T5) and a control IOL, AcrySof single

piece, model SA60AT.Approximately 250

sub-jects were implanted with SA60TT and 250

subjects were implanted with SA60AT All

subjects were followed for 1 year following

first eye implantation

8.3.1 Visual Acuity Outcomes

At the 80–100 day visit, 100% (n = 77) of toric subjects and 97.1% (n = 68) of control sub-

jects achieved BSCVA 20/40 or better In

com-paring UCVA, 94.6% (n = 74) of toric subjects while only 73.1% (n = 67) of control subjects

achieved 20/40 or better (Table 8.1)

Table 8.1. Visual acuity (BSCVA and UCVA), all jects AcrySof toric IOL (SA60TT) compared to AcrySof IOL monofocal (SA60AT)

sub-80–100 day data SA60TT SA60AT

BSCVA n = 77 n = 68

20/20 or better 76.6% 67.6%

subjects subjects 20/25 or better 89.6% 91.2% 20/30 or better 97.4% 95.6% 20/40 or better 100 % 97.1% Worse than 20/40 0% 3%

UCVA n = 74 n = 67

20/20 or better 31.1% 11.9%

subjects subjects 20/25 or better 63.5% 26.7% 20/30 or better 83.8% 46.3% 20/40 or better 94.6% 73.1% Worse than 20/40 5.4 % 26.9%

Ngày đăng: 10/08/2014, 00:21

TỪ KHÓA LIÊN QUAN